Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,760.00
-30.00 (-0.63%)
At close: Sep 11, 2026

Optipharm.CO.,LTD Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,861-2,499-2,357-2,437-2,045-3,080
Depreciation & Amortization
1,6861,6741,6141,4331,1201,076
Loss (Gain) From Sale of Assets
1.716.24-0.97-1.06-3.051.76
Loss (Gain) From Sale of Investments
72.01-175.23-185.27-184.65-346.47-90.2
Loss (Gain) on Equity Investments
---1.490.350.29
Stock-Based Compensation
469.87704.8587.33--33.61-5.9
Provision & Write-off of Bad Debts
-0.01-0.783.35-0.2-0.331.29
Other Operating Activities
320.21673.56480.51362.29298.11-1,063
Change in Accounts Receivable
800.69-504.72288.1476.25-899.4-95.74
Change in Inventory
-73.48-504.55-28.1-261.97-42.84-339.3
Change in Accounts Payable
23424.48-89.16152.63-631.57226.52
Change in Other Net Operating Assets
-1,578-963.45-908.9-1,264187.121,399
Operating Cash Flow
71.23-1,555-595.5-1,723-2,396-1,969
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-649.19-2,507-1,677-1,672-4,572-725.18
Sale of Property, Plant & Equipment
2.221.429.961.75.9311.81
Sale (Purchase) of Intangibles
-47.42-38.05-58.71-65.25-32.27-32.26
Investment in Securities
3,3713,2262,409-1,8542,621-6,789
Other Investing Activities
165.77131.02317.03--147.56
Investing Cash Flow
2,842813.611,020-3,589-1,978-7,387

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-10,31013,7007,7005,2005,100
Total Debt Issued
10,31010,31013,7007,7005,2005,100
Short-Term Debt Repaid
--10,750-12,560-5,560-3,560-3,560
Long-Term Debt Repaid
--163.73-197.01-147.29-130.41-156.45
Total Debt Repaid
-10,889-10,914-12,757-5,707-3,690-3,716
Net Debt Issued (Repaid)
-578.63-603.73942.991,9931,5101,384
Issuance of Common Stock
----250.5435
Other Financing Activities
---0-0-0-0
Financing Cash Flow
-578.63-603.73942.991,9931,7601,819

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
---0-0--
Net Cash Flow
2,335-1,3451,367-3,319-2,613-7,538

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-577.96-4,062-2,273-3,395-6,968-2,695
Free Cash Flow Growth
------
Free Cash Flow Margin
-2.45%-18.18%-11.58%-19.54%-43.53%-18.90%
Free Cash Flow Per Share
-39.28-276.86-155.29-231.26-477.10-185.50
Levered Free Cash Flow
664.29-2,578-1,010-2,006-6,486-2,171
Unlevered Free Cash Flow
969.2-2,263-669.33-1,708-6,265-2,062

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
617.58382.85516.81463.38319.85158.37
Cash Income Tax Paid
--25.71-14.8936.5836.09-31.66
Change in Working Capital
-616.95-1,948-738.06-897.07-1,3871,190